13 research outputs found
Interaction between an adcy3 genetic variant and two weight-lowering diets affecting body fatness and body composition outcomes depending on macronutrient distribution: a randomized trial
The adenylate cyclase 3 (ADCY3) gene is involved in the regulation of several metabolic
processes including the development and function of adipose tissue. The effects of the ADCY3
rs10182181 genetic variant on changes in body composition depending on the macronutrient
distribution intake after 16 weeks of the dietary intervention were tested. The ADCY3 genetic
variant was genotyped in 147 overweight or obese subjects, who were randomly assigned to one
of the two diets varying in macronutrient content: a moderately-high-protein diet and a low-fat
diet. Anthropometric and body composition measurements (DEXA scan) were recorded. Significant
interactions between the ADCY3 genotype and dietary intervention on changes in weight, waist
circumference, and body composition were found after adjustment for covariates. Thus, in the
moderately-high-protein diet group, the G allele was associated with a lower decrease of fat mass,
trunk and android fat, and a greater decrease in lean mass. Conversely, in the low-fat diet group
carrying the G allele was associated with a greater decrease in trunk, android, gynoid, and visceral
fat. Subjects carrying the G allele of the rs10182181 polymorphism may benefit more in terms of
weight loss and improvement of body composition measurements when undertaking a hypocaloric
low-fat diet as compared to a moderately-high-protein diet
Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the PrevenciĂłn con Dieta MediterrĂĄnea (PREDIMED) trial
Background
Arginine-derived metabolites are involved in oxidative and inflammatory processes related to endothelial functions and cardiovascular risks.
Objectives
We prospectively examined the associations of arginine catabolism metabolites with the risks of atrial fibrillation (AF) or heart failure (HF), and evaluated the potential modifications of these associations through Mediterranean diet (MedDiet) interventions in a large, primary-prevention trial.
Methods
Two nested, matched, case-control studies were designed within the PrevenciĂłn con Dieta MediterrĂĄnea (PREDIMED) trial. We selected 509 incident cases and 547 matched controls for the AF case-control study and 326 cases and 402 matched controls for the HF case-control study using incidence density sampling. Fasting blood samples were collected at baseline and arginine catabolism metabolites were measured using LC-tandem MS. Multivariable conditional logistic regression models were applied to test the associations between the metabolites and incident AF or HF. Interactions between metabolites and intervention groups (MedDiet groups compared with control group) were analyzed with the likelihood ratio test.
Results
Inverse association with incident AF was observed for arginine (OR per 1 SD, 0.83; 95% CI: 0.73â0.94), whereas a positive association was found for N1-acetylspermidine (OR for Q4 compared with Q1 1.58; 95% CI: 1.13â2.25). For HF, inverse associations were found for arginine (OR per 1 SD, 0.82; 95% CI: 0.69â0.97) and homoarginine (OR per 1 SD, 0.81; 95% CI: 0.68â0.96), and positive associations were found for the asymmetric dimethylarginine (ADMA) and symmetric dimethlyarginine (SDMA) ratio (OR per 1 SD, 1.19; 95% CI: 1.02â1.41), N1-acetylspermidine (OR per 1 SD, 1.34; 95% CI: 1.12â1.60), and diacetylspermine (OR per 1 SD, 1.20; 95% CI: 1.02â1.41). In the stratified analysis according to the dietary intervention, the lower HF risk associated with arginine was restricted to participants in the MedDiet groups (P-interaction = 0.044).
Conclusions
Our results suggest that arginine catabolism metabolites could be involved in AF and HF. Interventions with the MedDiet may contribute to strengthen the inverse association between arginine and the risk of HF. This trial was registered at controlled-trials.com as ISRCTN35739639
Phenotype and genotype predictors of BMI variability among European adults
Background/objective: Obesity is a complex and multifactorial disease resulting from the interactions among genetics, metabolic, behavioral, sociocultural and environmental factors. In this sense, the aim of the present study was to identify phenotype and genotype variables that could be relevant determinants of body mass index (BMI) variability.
Subjects/methods: In the present study, a total of 1050 subjects (798 females; 76%) were included. Least angle regression (LARS) analysis was used as regression model selection technique, where the dependent variable was BMI and the independent variables were age, sex, energy intake, physical activity level, and 16 polymorphisms previously related to obesity and lipid metabolism.
Results: The LARS analysis obtained the following formula for BMI explanation: (64.7 + 0.10 Ă age [years] + 0.42 Ă gender [0, men; 1, women] + -40.6 Ă physical activity [physical activity level] + 0.004 Ă energy intake [kcal] + 0.74 Ă rs9939609 [0 or 1-2 risk alleles] + -0.72 Ă rs1800206 [0 or 1-2 risk alleles] + -0.86 Ă rs1801282 [0 or 1-2 risk alleles] + 0.87 Ă rs429358 [0 or 1-2 risk alleles]. The multivariable regression model accounted for 21% of the phenotypic variance in BMI. The regression model was internally validated by the bootstrap method (r2 original data set = 0.208, mean r2 bootstrap data sets = 0.210).
Conclusion: In conclusion, age, physical activity, energy intake and polymorphisms in FTO, APOE, PPARG and PPARA genes are significant predictors of the BMI trait
Interplay of an Obesity-Based Genetic Risk Score with Dietary and Endocrine Factors on Insulin Resistance
This study aimed to nutrigenetically screen gene-diet and gene-metabolic interactions
influencing insulin resistance (IR) phenotypes. A total of 232 obese or overweight adults were
categorized by IR status: non-IR (HOMA-IR (homeostatic model assessment - insulin resistance)
index 2.5) and IR (HOMA-IR index > 2.5). A weighted genetic risk score (wGRS) was constructed
using 95 single nucleotide polymorphisms related to energy homeostasis, which were genotyped
by a next generation sequencing system. Body composition, the metabolic profile and lifestyle
variables were evaluated, where individuals with IR showed worse metabolic outcomes. Overall,
16 obesity-predisposing genetic variants were associated with IR (p < 0.10 in the multivariate model).
The wGRS strongly associated with the HOMA-IR index (adj. R squared = 0.2705, p < 0.0001).
Moreover, the wGRS positively interacted with dietary intake of cholesterol (P int. = 0.002), and with
serum concentrations of C-reactive protein (P int. = 0.008) regarding IR status, whereas a negative
interaction was found regarding adiponectin blood levels (P int. = 0.006). In conclusion, this study
suggests that interactions between an adiposity-based wGRS with nutritional and metabolic/endocrine
features influence IR phenotypes, which could facilitate the prescription of personalized nutrition
recommendations for precision prevention and management of IR and diabetes
Interaction between an adcy3 genetic variant and two weight-lowering diets affecting body fatness and body composition outcomes depending on macronutrient distribution: a randomized trial
The adenylate cyclase 3 (ADCY3) gene is involved in the regulation of several metabolic
processes including the development and function of adipose tissue. The effects of the ADCY3
rs10182181 genetic variant on changes in body composition depending on the macronutrient
distribution intake after 16 weeks of the dietary intervention were tested. The ADCY3 genetic
variant was genotyped in 147 overweight or obese subjects, who were randomly assigned to one
of the two diets varying in macronutrient content: a moderately-high-protein diet and a low-fat
diet. Anthropometric and body composition measurements (DEXA scan) were recorded. Significant
interactions between the ADCY3 genotype and dietary intervention on changes in weight, waist
circumference, and body composition were found after adjustment for covariates. Thus, in the
moderately-high-protein diet group, the G allele was associated with a lower decrease of fat mass,
trunk and android fat, and a greater decrease in lean mass. Conversely, in the low-fat diet group
carrying the G allele was associated with a greater decrease in trunk, android, gynoid, and visceral
fat. Subjects carrying the G allele of the rs10182181 polymorphism may benefit more in terms of
weight loss and improvement of body composition measurements when undertaking a hypocaloric
low-fat diet as compared to a moderately-high-protein diet
Interplay of an Obesity-Based Genetic Risk Score with Dietary and Endocrine Factors on Insulin Resistance
This study aimed to nutrigenetically screen gene-diet and gene-metabolic interactions
influencing insulin resistance (IR) phenotypes. A total of 232 obese or overweight adults were
categorized by IR status: non-IR (HOMA-IR (homeostatic model assessment - insulin resistance)
index 2.5) and IR (HOMA-IR index > 2.5). A weighted genetic risk score (wGRS) was constructed
using 95 single nucleotide polymorphisms related to energy homeostasis, which were genotyped
by a next generation sequencing system. Body composition, the metabolic profile and lifestyle
variables were evaluated, where individuals with IR showed worse metabolic outcomes. Overall,
16 obesity-predisposing genetic variants were associated with IR (p < 0.10 in the multivariate model).
The wGRS strongly associated with the HOMA-IR index (adj. R squared = 0.2705, p < 0.0001).
Moreover, the wGRS positively interacted with dietary intake of cholesterol (P int. = 0.002), and with
serum concentrations of C-reactive protein (P int. = 0.008) regarding IR status, whereas a negative
interaction was found regarding adiponectin blood levels (P int. = 0.006). In conclusion, this study
suggests that interactions between an adiposity-based wGRS with nutritional and metabolic/endocrine
features influence IR phenotypes, which could facilitate the prescription of personalized nutrition
recommendations for precision prevention and management of IR and diabetes
Association between a new dietary protein quality index and micronutrient intake adequacy: a cross-sectional study in a young adult Spanish Mediterranean cohort
PURPOSE: There is no evidence of a dietary index that measures not only the quantity but also the quality of protein. The aim is to investigate the association between a new dietary protein quality index (PQI) and micronutrient intake adequacy in a Mediterranean cohort. DESIGN: We assessed 17,535 participantsâ diet at baseline using a semi-quantitative FFQ. The PQI was calculated according to the ratio of protein (g/d) sources: [fish, seafood, lean meat, pulses, eggs, nuts, low-fat dairy, and whole grains]/[red and ultra-processed meats, whole-fat or semi-skimmed dairy, potatoes and refined grains]. Participants were classified into quintiles of PQI. We evaluated the intakes of Fe, Cr, I, K, Mg, Ca, P, Na, Se, Zn and vitamins A, B1, B2, B3, B6, B12, C, E and folic acid. Micronutrient adequacy was evaluated using DRIs. Logistic regression analysis was used to assess the micronutrient adequacy according to quintiles of PQI. RESULTS: In this cross-sectional analysis, a total of 24.2% and 4.3% participants did not to meet DRIs inââ„â4 andââ„â8 micronutrients, respectively. The odds of failing to meetââ„â4 andââ„â8 DRI were lower in participants in the highest quintile of protein quality (ORâ=â0.22; IC 95%â=â0.18, 0.26; P-trendâ<â0.001; and ORâ=â0.08; IC 95%â=â0.05, 0.14; P-trendâ<â0.001, respectively) as compared to participants in the lowest quintile. CONCLUSION: Higher PQI was found to be strongly associated with better micronutrient intake adequacy in this Mediterranean cohort. The promotion of high-quality protein intake may be helpful for a more adequate intake of micronutrients. The odds of failing to meet certain numbers of DRIs were lower rather than saying lower risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00394-022-02991-z
Macronutrient-specific effect of the MTNR1B genotype on lipid levels in response to 2 year weight-loss diets
Compelling evidence indicates that lipid metabolism is in partial control of the circadian system. In this context, it has been reported that the melatonin receptor 1B (MTNR1B) genetic variant influences the dynamics of melatonin secretion, which is involved in the circadian system as a chronobiotic. The objective was to analyze whether the MTNR1B rs10830963 genetic variant was related to changes in lipid levels in response to dietary interventions with different macronutrient distribution in 722 overweight/obese subjects from the POUNDS Lost trial. We did not find a significant association between the MTNR1B genotype and changes in lipid metabolism
A remote nutritional intervention to change the dietary habits of patients undergoing ablation of atrial fibrillation: randomized controlled trial
Background: The Prevention With Mediterranean Diet (PREDIMED) trial supported the effectiveness of a nutritional intervention conducted by a dietitian to prevent cardiovascular disease. However, the effect of a remote intervention to follow the Mediterranean diet has been less explored.
Objective: This study aims to assess the effectiveness of a remotely provided Mediterranean dietâbased nutritional intervention in obtaining favorable dietary changes in the context of a secondary prevention trial of atrial fibrillation (AF).
Methods: The PREvention of recurrent arrhythmias with Mediterranean diet (PREDIMAR) study is a 2-year multicenter, randomized, controlled, single-blinded trial to assess the effect of the Mediterranean diet enriched with extra virgin olive oil (EVOO) on the prevention of atrial tachyarrhythmia recurrence after catheter ablation. Participants in sinus rhythm after ablation were randomly assigned to an intervention group (Mediterranean diet enriched with EVOO) or a control group (usual clinical care). The remote nutritional intervention included phone contacts (1 per 3 months) and web-based interventions with provision of dietary recommendations, and participants had access to a web page, a mobile app, and printed resources. The information is divided into 6 areas: Recommended foods, Menus, News and Online resources, Practical tips, Mediterranean diet classroom, and Your personal experience. At baseline and at 1-year and 2-year follow-up, the 14-item Mediterranean Diet Adherence Screener (MEDAS) questionnaire and a semiquantitative food frequency questionnaire were collected by a dietitian by phone
A remote nutritional intervention to change the dietary habits of patients undergoing ablation of atrial fibrillation: randomized controlled trial
Background: The Prevention With Mediterranean Diet (PREDIMED) trial supported the effectiveness of a nutritional intervention conducted by a dietitian to prevent cardiovascular disease. However, the effect of a remote intervention to follow the Mediterranean diet has been less explored.
Objective: This study aims to assess the effectiveness of a remotely provided Mediterranean dietâbased nutritional intervention in obtaining favorable dietary changes in the context of a secondary prevention trial of atrial fibrillation (AF).
Methods: The PREvention of recurrent arrhythmias with Mediterranean diet (PREDIMAR) study is a 2-year multicenter, randomized, controlled, single-blinded trial to assess the effect of the Mediterranean diet enriched with extra virgin olive oil (EVOO) on the prevention of atrial tachyarrhythmia recurrence after catheter ablation. Participants in sinus rhythm after ablation were randomly assigned to an intervention group (Mediterranean diet enriched with EVOO) or a control group (usual clinical care). The remote nutritional intervention included phone contacts (1 per 3 months) and web-based interventions with provision of dietary recommendations, and participants had access to a web page, a mobile app, and printed resources. The information is divided into 6 areas: Recommended foods, Menus, News and Online resources, Practical tips, Mediterranean diet classroom, and Your personal experience. At baseline and at 1-year and 2-year follow-up, the 14-item Mediterranean Diet Adherence Screener (MEDAS) questionnaire and a semiquantitative food frequency questionnaire were collected by a dietitian by phone